Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens

The cystic fibrosis (CF) airway microbiome is complex; polymicrobial infections are common, and the presence of fastidious bacteria including anaerobes make culture-based diagnosis challenging. Quantitative real-time PCR (qPCR) offers a culture-independent method for bacterial quantification that may improve diagnosis of CF airway infections; however, the reliability of qPCR applied to CF airway specimens is unknown. We sought to determine the reliability of nine specific bacterial qPCR assays (total bacteria, three typical CF pathogens, and five anaerobes) applied to CF airway specimens. Airway and salivary specimens from clinically stable pediatric CF subjects were collected. Quantitative PCR assay repeatability was determined using triplicate reactions. Split-sample measurements were performed to measure variability introduced by DNA extraction. Results from qPCR were compared to standard microbial culture for Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae, common pathogens in CF. We obtained 84 sputa, 47 oropharyngeal and 27 salivary specimens from 16 pediatric subjects with CF. Quantitative PCR detected bacterial DNA in over 97% of specimens. All qPCR assays were highly reproducible at quantities ≥102 rRNA gene copies/reaction with coefficient of variation less than 20% for over 99% of samples. There was also excellent agreement between samples processed in duplicate. Anaerobic bacteria were highly prevalent and were detected in mean quantities similar to that of typical CF pathogens. Compared to a composite gold standard, qPCR and culture had variable sensitivities for detection of P. aeruginosa, S. aureus and H. influenzae from CF airway samples. By reliably quantifying fastidious airway bacteria, qPCR may improve our understanding of polymicrobial CF lung infections, progression of lung disease and ultimately improve antimicrobial treatments.

[1]  D. Goldmann,et al.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent , 1980, Journal of clinical microbiology.

[2]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[3]  D H Persing,et al.  Molecular diagnostics of infectious diseases , 1999 .

[4]  N. Pace A molecular view of microbial diversity and the biosphere. , 1997, Science.

[5]  R. Proctor,et al.  Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. , 1998, The Journal of infectious diseases.

[6]  J. Emerson,et al.  Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Emerson,et al.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis , 1999, Pediatric pulmonology.

[8]  P. Beringer,et al.  Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features , 2000, Current opinion in pulmonary medicine.

[9]  A. van Belkum,et al.  Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. , 2000, FEMS immunology and medical microbiology.

[10]  F. Accurso,et al.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. , 2001, American journal of respiratory and critical care medicine.

[11]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.

[12]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[13]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[14]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[15]  Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling , 2003, Journal of Clinical Microbiology.

[16]  C. E. Caldon,et al.  Carious Dentine Provides a Habitat for a Complex Array of Novel Prevotella-Like Bacteria , 2004, Journal of Clinical Microbiology.

[17]  G. Rogers,et al.  Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.

[18]  L. Saiman Microbiology of early CF lung disease. , 2004, Paediatric respiratory reviews.

[19]  P. Savelkoul,et al.  Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. , 2005, FEMS immunology and medical microbiology.

[20]  V. Raia,et al.  BMC Infectious Diseases BioMed Central Research article , 2006 .

[21]  M. Surette,et al.  Cystic fibrosis: a polymicrobial infectious disease. , 2006, Future microbiology.

[22]  P. Morris,et al.  Bmc Ear, Nose and Throat Disorders Open Access Measuring Nasal Bacterial Load and Its Association with Otitis Media , 2022 .

[23]  G. Rogers,et al.  Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis , 2006, Journal of Clinical Microbiology.

[24]  T. Asahara,et al.  Sensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR , 2006, Applied and Environmental Microbiology.

[25]  P. Savelkoul,et al.  Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. , 2007, Journal of periodontology.

[26]  N. Pace,et al.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.

[27]  P. Berche,et al.  Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. , 2007, Journal of microbiological methods.

[28]  J. Sarles,et al.  Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients , 2008, PloS one.

[29]  H. D. Vanguilder,et al.  Twenty-five years of quantitative PCR for gene expression analysis. , 2008, BioTechniques.

[30]  M. Wolfgang,et al.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[31]  S. Molin,et al.  In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.

[32]  R. Knight,et al.  Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex , 2008, Nature Methods.

[33]  P. Brigidi,et al.  Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[34]  M. Surette,et al.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.

[35]  E. Goldstein,et al.  National hospital survey of anaerobic culture and susceptibility methods: III. , 2008, Anaerobe.

[36]  B. Rubin Mucus, phlegm, and sputum in cystic fibrosis. , 2009, Respiratory care.

[37]  G. Döring,et al.  Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  J. Harris,et al.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures , 2010, Pediatric pulmonology.

[39]  J. Rolain,et al.  Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.